FIELD: medicine and pharmaceuticals.
SUBSTANCE: invention relates to pharmaceuticals and medicine and can be used as a medicine for gastrointestinal disorders, such as functional dyspepsia syndrome (non-ulcer dyspepsia). As a medicine, it is proposed to use an analogue of leyenkephalin Dalargin.
EFFECT: said invention minimizes side effects in treatment of functional dyspepsia.
2 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATING FUNCTIONAL GASTROINTESTINAL DISEASES | 2020 |
|
RU2740750C1 |
| COMBINATION FOR TREATING FUNCTIONAL GASTROINTESTINAL DISEASES | 2019 |
|
RU2733719C1 |
| USE OF TRIMEBUTINE MALEATE FOR PREVENTING AND TREATING INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACT | 2024 |
|
RU2821790C1 |
| WAY OF TREATMENT OF SPASTIC AND PAINFUL SYNDROMES AT PATIENTS WITH CONSEQUENCES OF VERTEBRAL-SPINAL TRAUMA | 2007 |
|
RU2362580C1 |
| ANTIANGINAL AGENT | 2001 |
|
RU2200026C2 |
| ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR TREATING IRRITABLE BOWEL SYNDROME, CONTAINING INTESTINAL PERISTALSIS CONTROLLER, AGENT PREVENTING DELAY OF GASES, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF | 2011 |
|
RU2581920C2 |
| APPLICATION OF ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS (mGLuR5), ESPECIALLY AFQ056, FOR TREATMENT OF GASTROINTESTINAL TRACT (GIT), ESPECIALLY GASTROESOPHAGEAL REFLUX (GER) | 2006 |
|
RU2422138C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF HARD PERORAL DRUG FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES | 2009 |
|
RU2418576C2 |
| PHARMACEUTICAL COMPOSITIONS AND THEIR USING IN TREATMENT OF GASTROENTERIC DISEASES | 2000 |
|
RU2264215C2 |
| APPLICATION OF METHYL NALTREXONE FOR TREATING IRRITABLE COLON SYNDROME | 2004 |
|
RU2373936C2 |
